FDA Approves Chemo-Free Frontline Regimen for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
New York (May 15, 2019) – The U.S. Food and Drug Administration (FDA) announced it…
New York (May 15, 2019) – The U.S. Food and Drug Administration (FDA) announced it…
New York, NY –The U.S. Food and Drug Administration (FDA) announced it has approved the…
New York, NY – The U.S. Food and Drug Administration (FDA) announced it has expanded…
The Lymphoma Research Foundation extends its heartfelt condolences to the family, loved ones and colleagues…
New York, NY – The U.S. Food and Drug Administration (FDA) announced it has approved…
New York, NY (August 27, 2018) – The U.S. Food and Drug Administration (FDA) announced…
New York, NY (August 8, 2018) –The U.S. Food and Drug Administration (FDA) announced it…
New York, NY (June 13, 2018) –The U.S. Food and Drug Administration (FDA) granted accelerated…
New York, NY (June 8, 2018) – The U.S. Food and Drug Administration (FDA) announced…